Dare Bioscience, Inc. Payments of Debt Issuance Costs
Dare Bioscience, Inc. (DARE) reported Payments of Debt Issuance Costs of $359.00 thousand for the 12-month period ending 2015-12-31, per its 10-K/A filed 2017-06-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2017-06-13
- Dare Bioscience, Inc. payments of debt issuance costs for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. payments of debt issuance costs for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. payments of debt issuance costs for the quarter ending 2015-06-30 was $0.00.
- Dare Bioscience, Inc. payments of debt issuance costs for the quarter ending 2015-03-31 was $359.00K.
- Dare Bioscience, Inc. payments of debt issuance costs for fiscal 2015 was $359.00K, a 61.71% increase from fiscal 2014.
- Dare Bioscience, Inc. payments of debt issuance costs for fiscal 2014 was $222.00K, a 40.48% decline from fiscal 2013.
- Dare Bioscience, Inc. payments of debt issuance costs for fiscal 2013 was $373.00K, a 9225.00% increase from fiscal 2012.
- Dare Bioscience, Inc. payments of debt issuance costs for fiscal 2012 was $4.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | $0.00 derived: sum of 2 quarters · filed 2017-06-13 | $0.00 derived: sum of 3 quarters · filed 2017-06-13 | $359.00K 10-K/A · filed 2017-06-13 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $359.00K 10-Q · filed 2016-11-03 | $393.00K derived: sum of 4 quarters · filed 2017-06-13 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $359.00K 10-Q · filed 2016-08-04 | $393.00K derived: sum of 3 quarters · filed 2017-06-13 | $402.00K derived: sum of 4 quarters · filed 2017-06-13 |
| 2015-03-31 | $359.00K 10-Q · filed 2016-05-02 | $393.00K derived: sum of 2 quarters · filed 2017-06-13 | $402.00K derived: sum of 3 quarters · filed 2017-06-13 | |
| 2014-12-31 | $34.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | $43.00K derived: sum of 2 quarters · filed 2017-06-13 | $222.00K 10-K/A · filed 2017-06-13 | |
| 2014-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $188.00K 10-Q · filed 2015-11-16 | ||
| 2014-06-30 | $179.00K 10-Q · filed 2015-08-06 | |||
| 2013-12-31 | $373.00K 10-K · filed 2016-03-10 | |||
| 2012-12-31 | $4.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |